Hydrotherapy CP and Lying Down to Sitting Position

The Effect of a Specific Hydrotherapy Program on the Movement From Lying Down to Sitting Position for Children With Cerebral Palsy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05091892

Enrollment

Registered

2021-10-25

Start date

2021-09-01

Completion date

2022-03-30

Last updated

2022-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

Cerebral palsy, hydrotherapy, Neurodevelopmental treatment, Lying down, Sitting

Brief summary

The purpose of this study is to investigate the effect of a very specific hydrotherapy programm on the movement from lying down to sitting position for children with CP

Detailed description

40 children aged 5-11 years with cerebral palsy and difficulty in the transfer activity from lying down to sitting position were randomly divided into 2 groups of 20 children, a land group and a water group. The children of the land attended a neurodevelopmental treatment program and the water group a very specific program in hydrotherapy on combined rotation at all levels. The water program was implemented by specialized physiotherapists in hydrotherapy. The duration of the program for both groups was 3 months. On the first and last day of the intervention, an evaluation of all children was performed using the GMFM and PBS evaluation tests of the evaluation parameters of the transfer from the lying position to the sitting position.

Interventions

OTHERHydrotherapy programm

Treatment

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

DOUBLE (Subject, Investigator)

Intervention model description

2 equal groups

Eligibility

Sex/Gender

ALL

Age

5 Years to 11 Years

Healthy volunteers

Inclusion criteria

* Cerebral palsy * DIfficulties from lying down to sitting posistion

Exclusion criteria

* Surgery or injection of botilium toxin in the last year. * Scheduled surgery or injection of botilium toxin. * Uncontrolled seizures. * Do not run elementary commands or play a test representation. * Autism. * Syndromes without OP. * Serious vision problem. * Absence from the treatment program for more than a week.

Design outcomes

Primary

Measure	Time frame	Description
GMFM	3 months	Gross Motor Function Measurement
PBS	3 months	Paediatric Balance test

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026